Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

24
Summary: She has become one of the country’s leading advocates on patient-centered drug development and clinical trial design    The Alpha-1 Project (TAP) announces the appointment of Karen Erickson as Chief Operating Officer, a new...

[Read More...]

22
Apic Bio Launches to Advance First-in-Class Gene Therapy for Treatment of Alpha-1 Antitrypsin Deficiency (Alpha 1)                       ...

[Read More...]

12
Fellowship will advance therapeutic strategies for Alpha-1 Antitrypsin DeficiencyCiting “substantial progress” in the first year of a postdoctoral fellowship at the National Institutes of Health’s (NIH) National Center for Advancing Translational Sci...

[Read More...]

17
Inhibrx’s AAT-Fc therapeutic should benefit patients with enhanced efficacy and less frequent dosing; Alpha-1 Project collaborates with industry to accelerate drug developmentLA JOLLA, CA and MIAMI, FL, September 16, 2015—Inhibrx and The ...

[Read More...]

20
- RNAi Therapeutic ARC-AAT Induces Dose Dependent Reductions in Mutant AAT Protein of Greater than 95 Percent in Preclinical Studies- Long Duration of Effect with AAT Remaining Reduced by More than 80% at 6 Weeks after a Single Dose- Company ...

[Read More...]

Page 3 of 5First   Previous   1  2  [3]  4  5  Next   Last